Emmaus Life Sciences Stock Analysis
| EMMA Stock | USD 0.01 0.0001 0.71% |
Emmaus Life Sciences holds a debt-to-equity ratio of -0.041. With a high degree of financial leverage come high-interest payments, which usually reduce Emmaus Life's Earnings Per Share (EPS).
Given that Emmaus Life's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Emmaus Life is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Emmaus Life to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Emmaus Life is said to be less leveraged. If creditors hold a majority of Emmaus Life's assets, the OTC Stock is said to be highly leveraged.
Emmaus Life Sciences is overvalued with Real Value of 0.0118 and Hype Value of 0.01. The main objective of Emmaus Life otc analysis is to determine its intrinsic value, which is an estimate of what Emmaus Life Sciences is worth, separate from its market price. There are two main types of Emmaus Life's stock analysis: fundamental analysis and technical analysis.
The Emmaus Life otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Emmaus Life's ongoing operational relationships across important fundamental and technical indicators.
Emmaus |
Emmaus OTC Stock Analysis Notes
About 39.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Emmaus Life Sciences last dividend was issued on the 18th of July 2019. The entity had 1:6 split on the 18th of July 2019. Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.The quote for Emmaus Life Sciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Emmaus Life Sciences call MD MPH at 310 214 0065 or check out https://www.emmausmedical.com.Emmaus Life Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Emmaus Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Emmaus Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Emmaus Life Sciences is way too risky over 90 days horizon | |
| Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
| Emmaus Life Sciences appears to be risky and price may revert if volatility continues | |
| Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
| Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
Emmaus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Emmaus Life's market, we take the total number of its shares issued and multiply it by Emmaus Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Emmaus Profitablity
Emmaus Life's profitability indicators refer to fundamental financial ratios that showcase Emmaus Life's ability to generate income relative to its revenue or operating costs. If, let's say, Emmaus Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Emmaus Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Emmaus Life's profitability requires more research than a typical breakdown of Emmaus Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65. Technical Drivers
As of the 2nd of February, Emmaus Life shows the Downside Deviation of 10.26, coefficient of variation of 1083.66, and Mean Deviation of 5.5. Emmaus Life Sciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for Emmaus Life Sciences, which can be compared to its peers.Emmaus Life Sciences Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Emmaus Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Emmaus Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Emmaus Life Outstanding Bonds
Emmaus Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Emmaus Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Emmaus bonds can be classified according to their maturity, which is the date when Emmaus Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Emmaus Life Predictive Daily Indicators
Emmaus Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Emmaus Life otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0139 | |||
| Day Typical Price | 0.0139 | |||
| Price Action Indicator | (0.00005) | |||
| Period Momentum Indicator | (0.0001) | |||
| Relative Strength Index | 56.4 |
Emmaus Life Forecast Models
Emmaus Life's time-series forecasting models are one of many Emmaus Life's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Emmaus Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Emmaus Life Sciences Debt to Cash Allocation
Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity.Emmaus Life Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Emmaus Life's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Emmaus Life, which in turn will lower the firm's financial flexibility.Emmaus Life Corporate Bonds Issued
Most Emmaus bonds can be classified according to their maturity, which is the date when Emmaus Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Emmaus OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Emmaus Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emmaus shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Emmaus Life. By using and applying Emmaus OTC Stock analysis, traders can create a robust methodology for identifying Emmaus entry and exit points for their positions.
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Emmaus Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Complementary Tools for Emmaus OTC Stock analysis
When running Emmaus Life's price analysis, check to measure Emmaus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emmaus Life is operating at the current time. Most of Emmaus Life's value examination focuses on studying past and present price action to predict the probability of Emmaus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emmaus Life's price. Additionally, you may evaluate how the addition of Emmaus Life to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |